Literature DB >> 26735017

Cancer: Bet on drug resistance.

Jeff Settleman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26735017     DOI: 10.1038/nature16863

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

3.  A comprehensive transcriptional portrait of human cancer cell lines.

Authors:  Christiaan Klijn; Steffen Durinck; Eric W Stawiski; Peter M Haverty; Zhaoshi Jiang; Hanbin Liu; Jeremiah Degenhardt; Oleg Mayba; Florian Gnad; Jinfeng Liu; Gregoire Pau; Jens Reeder; Yi Cao; Kiran Mukhyala; Suresh K Selvaraj; Mamie Yu; Gregory J Zynda; Matthew J Brauer; Thomas D Wu; Robert C Gentleman; Gerard Manning; Robert L Yauch; Richard Bourgon; David Stokoe; Zora Modrusan; Richard M Neve; Frederic J de Sauvage; Jeffrey Settleman; Somasekar Seshagiri; Zemin Zhang
Journal:  Nat Biotechnol       Date:  2014-12-08       Impact factor: 54.908

Review 4.  Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure.

Authors:  Jun Qi
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-01       Impact factor: 10.005

Review 5.  Mechanisms of acquired resistance to targeted cancer therapies.

Authors:  Mark R Lackner; Timothy R Wilson; Jeff Settleman
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

6.  The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

Authors:  Yingzi Wang; Andrei V Krivtsov; Amit U Sinha; Trista E North; Wolfram Goessling; Zhaohui Feng; Leonard I Zon; Scott A Armstrong
Journal:  Science       Date:  2010-03-26       Impact factor: 47.728

7.  BET inhibitor resistance emerges from leukaemia stem cells.

Authors:  Chun Yew Fong; Omer Gilan; Enid Y N Lam; Alan F Rubin; Sarah Ftouni; Dean Tyler; Kym Stanley; Devbarna Sinha; Paul Yeh; Jessica Morison; George Giotopoulos; Dave Lugo; Philip Jeffrey; Stanley Chun-Wei Lee; Christopher Carpenter; Richard Gregory; Robert G Ramsay; Steven W Lane; Omar Abdel-Wahab; Tony Kouzarides; Ricky W Johnstone; Sarah-Jane Dawson; Brian J P Huntly; Rab K Prinjha; Anthony T Papenfuss; Mark A Dawson
Journal:  Nature       Date:  2015-09-14       Impact factor: 49.962

Review 8.  Myc's broad reach.

Authors:  Martin Eilers; Robert N Eisenman
Journal:  Genes Dev       Date:  2008-10-15       Impact factor: 11.361

9.  Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.

Authors:  Philipp Rathert; Mareike Roth; Tobias Neumann; Felix Muerdter; Jae-Seok Roe; Matthias Muhar; Sumit Deswal; Sabine Cerny-Reiterer; Barbara Peter; Julian Jude; Thomas Hoffmann; Łukasz M Boryń; Elin Axelsson; Norbert Schweifer; Ulrike Tontsch-Grunt; Lukas E Dow; Davide Gianni; Mark Pearson; Peter Valent; Alexander Stark; Norbert Kraut; Christopher R Vakoc; Johannes Zuber
Journal:  Nature       Date:  2015-09-14       Impact factor: 49.962

10.  Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

Authors:  Shaokun Shu; Charles Y Lin; Housheng Hansen He; Robert M Witwicki; Doris P Tabassum; Justin M Roberts; Michalina Janiszewska; Sung Jin Huh; Yi Liang; Jeremy Ryan; Ernest Doherty; Hisham Mohammed; Hao Guo; Daniel G Stover; Muhammad B Ekram; Jonathan Brown; Clive D'Santos; Ian E Krop; Deborah Dillon; Michael McKeown; Christopher Ott; Jun Qi; Min Ni; Prakash K Rao; Melissa Duarte; Shwu-Yuan Wu; Cheng-Ming Chiang; Lars Anders; Richard A Young; Eric Winer; Antony Letai; William T Barry; Jason S Carroll; Henry Long; Myles Brown; X Shirley Liu; Clifford A Meyer; James E Bradner; Kornelia Polyak
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

  10 in total
  13 in total

Review 1.  Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.

Authors:  Yusuke Furukawa; Jiro Kikuchi
Journal:  Int J Hematol       Date:  2016-07-13       Impact factor: 2.490

Review 2.  Marked for death: targeting epigenetic changes in cancer.

Authors:  Sophia Xiao Pfister; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

3.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

4.  Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.

Authors:  Marco Segatto; Raffaella Fittipaldi; Fabrizio Pin; Roberta Sartori; Kyung Dae Ko; Hossein Zare; Claudio Fenizia; Gianpietro Zanchettin; Elisa Sefora Pierobon; Shinji Hatakeyama; Cosimo Sperti; Stefano Merigliano; Marco Sandri; Panagis Filippakopoulos; Paola Costelli; Vittorio Sartorelli; Giuseppina Caretti
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

5.  A dynamical framework for complex fractional killing.

Authors:  Richard Ballweg; Andrew L Paek; Tongli Zhang
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.

Authors:  Xudong Fu; Xinjun Wang; Shaolong Zhou; Yanyan Zhang
Journal:  Int J Nanomedicine       Date:  2017-05-16

7.  Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.

Authors:  Shiyao Sui; Jian Zhang; Shouping Xu; Qin Wang; Peiyuan Wang; Da Pang
Journal:  Cell Death Dis       Date:  2019-04-15       Impact factor: 8.469

Review 8.  Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.

Authors:  Stanislav Filip; Veronika Vymetalkova; Jiri Petera; Ludmila Vodickova; Ondrej Kubecek; Stanislav John; Filip Cecka; Marketa Krupova; Monika Manethova; Klara Cervena; Pavel Vodicka
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

9.  Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4.

Authors:  Jack Calder; Amy Nagelberg; Jennifer Luu; Daniel Lu; William W Lockwood
Journal:  Oncogenesis       Date:  2021-03-12       Impact factor: 7.485

Review 10.  The Different Mechanisms of Cancer Drug Resistance: A Brief Review.

Authors:  Behzad Mansoori; Ali Mohammadi; Sadaf Davudian; Solmaz Shirjang; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.